Market Overview

Obalon Wins 2 US Patents For Intragastric Balloon System

Obalon Wins 2 US Patents For Intragastric Balloon System

Shares of micro-cap Obalon Therapeutics Inc (NASDAQ: OBLN) traded higher Tuesday after the company announced it has obtained two new U.S. patents covering its proprietary intragastric balloon system.

The Obalon balloon system is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity.

Obalon Therapeutics shares were trading higher by 4.27% at 64 cents at the time of publication Tuesday. 

Related Links:

Obalon Ticks Higher Amid Patent Abstract For Intragastric Device

Premarket Approval Doc For Balloon System Sends Obalon Shares Sharply Higher

Posted-In: Biotech News Penny Stocks Markets General Best of Benzinga


Related Articles (OBLN)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

41 Stocks Moving In Tuesday's Mid-Day Session

Analyst: Prime Day 'Locks In' Customers For Amazon's Ecosystem